HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth [NA]
The clinical trial evaluating integrated mental health treatment with HIV prevention for court-involved youth has completed. The sponsor lis…
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Rewarding Adherence Program - an Intervention Using Small Prizes Allocated by a Prize Drawing to Increase ARV Adherence [NA]
Clinical trial evaluating a prize-drawing based adherence program to improve antiretroviral therapy adherence in people with HIV.
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men (MSM) in Two Vietnamese Cities [NA]
This completed clinical trial evaluated the implementation of a sexual health intervention for young men who have sex with men (MSM) in two …
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Asha HIV Health Promotion Intervention in India [Phase 1, Phase 2]
The Asha HIV Health Promotion Intervention trial in India completed Phase 1 and Phase 2 studies.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses [Phase 1]
This Phase 1 trial from Imperial College London evaluated immunisation strategies using DNA, MVA, and CN54 gp140 with the GLA-AF adjuvant to…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-09-26FDA Approved: ABACAVIR — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Abacavir from Camber Pharmaceuticals, resulting in labeling changes for the product.
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: Tenofovir Pharmacology in Older HIV Infected Individuals
A completed clinical trial update describing the pharmacology of tenofovir in older adults with HIV infection.
-
FDA approval · 2016-09-26FDA Approved: ABACAVIR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic abacavir under an Original Application (ANDA) for HIV-1 infection.
-
FDA label_change · 2016-09-22FDA Approved: PREZCOBIX — Supplemental Application (Janssen Products, LP)
FDA approved a supplemental application for PREZCOBIX (darunavir ethanolate and cobicistat), updating the labeling for this HIV-1 infection …
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Randomized Control Trial of Family-Based HIV Prevention for Latinos [Phase 2]
A Phase 2 randomized controlled trial evaluating a family-based HIV prevention program for Latino families has completed. Sponsor: Universit…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART [EARLY_Phase 1]
This early-phase trial update compares malaria infection levels in HIV-infected infants and children on protease inhibitor–based HAART versu…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome [Phase 4]
Phase IV study of BMS-232632 in HIV-infected patients with metabolic syndrome was terminated.
-
CLINICAL_TRIALS research · 2016-09-16Clinical Trial Update: Knowledge Attitudes Beliefs and Practices Regarding HIV Among Teenagers in French Guiana
A completed clinical trial update reporting on knowledge, attitudes, beliefs, and practices regarding HIV among teenagers in French Guiana.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Knowledge Attitudes, Beliefs, and Practices Regarding HIV in Populations Living on the Maroni River
A completed clinical trial assessing knowledge, attitudes, beliefs, and practices regarding HIV among populations living along the Maroni Ri…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Lung HIV Microbiome Project (Michigan Site)
The University of Michigan's Lung HIV Microbiome Project at the Michigan site has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Knowledge Attitudes Beliefs and Practices Relative to HIV Among Sex Workers in French Guiana
Completed clinical trial (NCT02903563) assessing knowledge, attitudes, beliefs, and practices related to HIV among sex workers in French Gui…
-
FDA approval · 2016-09-15FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Kaletra (lopinavir/ritonavir) submitted by AbbVie.
-
FDA approval · 2016-09-15FDA Approved: APTIVUS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for APTIVUS (tipranavir) from Boehringer Ingelheim Pharmaceuticals, Inc., resulting in changes to th…
-
FDA approval · 2016-09-15FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) submitted by E.R. Squibb & Sons, L.L.C.
-
FDA approval · 2016-09-15FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie Inc.
-
FDA approval · 2016-09-15FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP.
-
FDA approval · 2016-09-15FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
FDA approved the supplemental application for STRIBILD (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate) from Gil…
-
FDA approval · 2016-09-15FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) from E.R. Squibb & Sons, L.L.C., updating its labeling and/or indicatio…
-
FDA approval · 2016-09-15FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) submitted by Gi…
-
FDA approval · 2016-09-15FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for Prezista (darunavir) from Janssen Products LP.